P Almi

486 total citations
21 papers, 336 citations indexed

About

P Almi is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, P Almi has authored 21 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in P Almi's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers) and Hepatitis B Virus Studies (8 papers). P Almi is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers) and Hepatitis B Virus Studies (8 papers). P Almi collaborates with scholars based in Italy, United States and Germany. P Almi's co-authors include Maurizio Zazzi, P. E. Valensin, C. Caudai, Andrea De Luca, Laura Romanó, Simona Di Giambenedetto, M Toti, Angelo De Milito, Francesco Saladini and Ilaria Vicenti and has published in prestigious journals such as Blood, PLoS ONE and Gut.

In The Last Decade

P Almi

20 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Almi Italy 13 189 177 162 116 33 21 336
Dennis Revie United States 9 137 0.7× 155 0.9× 118 0.7× 117 1.0× 75 2.3× 12 341
Lian-Fu Wang United States 9 319 1.7× 53 0.3× 348 2.1× 41 0.4× 17 0.5× 13 406
Ermei Yao United States 8 262 1.4× 69 0.4× 299 1.8× 57 0.5× 55 1.7× 11 371
A. Eiras Spain 9 138 0.7× 201 1.1× 94 0.6× 177 1.5× 46 1.4× 21 369
Chiara Taibi Italy 8 165 0.9× 58 0.3× 138 0.9× 61 0.5× 38 1.2× 36 262
Lahcen Wakrim Morocco 10 129 0.7× 192 1.1× 64 0.4× 178 1.5× 61 1.8× 37 388
J.A. McDonald United Kingdom 10 356 1.9× 53 0.3× 341 2.1× 38 0.3× 29 0.9× 12 418
Cecilia Parodi Argentina 11 147 0.8× 64 0.4× 76 0.5× 74 0.6× 18 0.5× 29 329
Patrizia Caligiuri Italy 10 177 0.9× 117 0.7× 131 0.8× 34 0.3× 17 0.5× 20 299
Muriel Pellerin France 6 281 1.5× 53 0.3× 363 2.2× 48 0.4× 41 1.2× 6 401

Countries citing papers authored by P Almi

Since Specialization
Citations

This map shows the geographic impact of P Almi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Almi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Almi more than expected).

Fields of papers citing papers by P Almi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Almi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Almi. The network helps show where P Almi may publish in the future.

Co-authorship network of co-authors of P Almi

This figure shows the co-authorship network connecting the top 25 collaborators of P Almi. A scholar is included among the top collaborators of P Almi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Almi. P Almi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caudai, C., Francesco Saladini, Simona Di Giambenedetto, et al.. (2017). Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy. Clinical Microbiology and Infection. 24(3). 308.e5–308.e8. 8 indexed citations
2.
Calise, S. John, Nicola Bizzaro, Thuy Minh Nguyen, et al.. (2016). Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection. PubMed. 7(1). 15–15. 12 indexed citations
3.
Luca, Andrea De, Simona Di Giambenedetto, Alessandra Lo Presti, et al.. (2015). Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors. Open Forum Infectious Diseases. 2(2). ofv043–ofv043. 28 indexed citations
4.
Franzetti, Marco, Alessia Lai, Francesco R. Simonetti, et al.. (2012). High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype. Journal of Antimicrobial Chemotherapy. 67(5). 1250–1253. 9 indexed citations
5.
Lai, Alessia, Francesco R. Simonetti, Gianguglielmo Zehender, et al.. (2012). HIV-1 Subtype F1 Epidemiological Networks among Italian Heterosexual Males Are Associated with Introduction Events from South America. PLoS ONE. 7(8). e42223–e42223. 26 indexed citations
6.
Vicenti, Ilaria, Andrea Rosi, Francesco Saladini, et al.. (2012). Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy. Journal of Antimicrobial Chemotherapy. 67(4). 984–987. 50 indexed citations
7.
Giambenedetto, Simona Di, Maurizio Zazzi, Paola Corsi, et al.. (2008). Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. Antiviral Therapy. 14(3). 359–369. 12 indexed citations
8.
Luca, Andrea De, Simona Di Giambenedetto, Laura Romanó, et al.. (2006). Frequency and Treatment‐Related Predictors of Thymidine‐Analogue Mutation Patterns in HIV‐1 Isolates after Unsuccessful Antiretroviral Therapy. The Journal of Infectious Diseases. 193(9). 1219–1222. 21 indexed citations
9.
Zazzi, Maurizio, Paola Corsi, Massimo Di Pietro, et al.. (2006). Evolution of the prevalence of HIV drug resistance patterns over 9 years of HAART and its relation with changes in the failing treatment regimens: an analysis of a large Italian database. 3 indexed citations
10.
Caudai, C., P. E. Valensin, Venkatakrishna Shyamala, et al.. (1998). Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons. Infection. 26(3). 151–154. 25 indexed citations
11.
Caudai, C., Davide Maimone, P Almi, et al.. (1997). The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C. Gut. 41(3). 411–412. 22 indexed citations
12.
Zazzi, Maurizio, Laura Romanó, Giulietta Venturi, et al.. (1997). Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. Journal of Medical Virology. 52(1). 20–25. 31 indexed citations
13.
Zazzi, Maurizio, Angelo De Milito, Laura Romanó, et al.. (1996). Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: Longitudinal evaluation of six patients under treatment. Infection. 24(6). 419–425. 12 indexed citations
14.
Zazzi, Maurizio, et al.. (1995). Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR. Journal of Clinical Microbiology. 33(1). 205–208. 16 indexed citations
15.
Almi, P, et al.. (1994). Intrafamilial hepatitis A outbreak: projection on the community in an area of Tuscany.. PubMed. 70(1-2). 439–42. 1 indexed citations
16.
Almi, P, et al.. (1989). [Epidemiology of hepatitis B virus infection in the personnel of a psychiatric hospital].. PubMed. 80(9). 1011–4. 4 indexed citations
17.
Lavarini, C, Patrizia Farci, E. Chiaberge, et al.. (1983). IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.. BMJ. 287(6401). 1254–1256. 19 indexed citations
18.
Rizzi, Rita, et al.. (1983). HBsAg/IgM complexes in serum of HBsAg carriers: partial characterization and clinical significance.. PubMed. 62(2). 137–44.
19.
Toti, M, et al.. (1983). Complexes between hbsag and igm in serum of patients with acute hepatitis. Journal of Medical Virology. 11(2). 139–145. 11 indexed citations
20.
Rizzi, Roberto, M Toti, P Almi, et al.. (1983). Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection. Infection and Immunity. 41(3). 950–958. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Revie Breakdown of academic impact, for papers by Lian-Fu Wang Breakdown of academic impact, for papers by Ermei Yao Breakdown of academic impact, for papers by A. Eiras Breakdown of academic impact, for papers by Chiara Taibi Breakdown of academic impact, for papers by Lahcen Wakrim Breakdown of academic impact, for papers by J.A. McDonald Breakdown of academic impact, for papers by Cecilia Parodi Breakdown of academic impact, for papers by Patrizia Caligiuri Breakdown of academic impact, for papers by Muriel Pellerin
Rankless by CCL
2026